Atlas Trials

Improving Post-Prandial Blood Glucose Control With Afrezza During Closed-Loop Therapy

Clinical trial NCT03234491 · COMPLETED

Trial details

NCT number
NCT03234491
Sponsor
Yale University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Post-Prandial HyperglycemiaPost-Prandial Hypoglycemia
Start date
2017-11-22
Primary completion
2019-07-22
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.